Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus and ablate sweat glands. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light. Cynosure sells its products globally under the Cynosure, Palomar and ConBio brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries.

Webcast ImageWebcast
Cynosure Acquires Assets of RF Medical Device Manufacturer Ellman International, Inc. Conference Call (Replay)
09/08/14 at 9:00 a.m. ET
Cynosure Acquires Assets of RF Medical Device Manufacturer Ellman International, Inc. Conference Call
Monday, September 8, 2014 9:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
CYNO (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$22.95
Change (%)0.00 (1.12%)
Volume130,947
Data as of 09/15/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

News Releases

September 10, 2014
Cynosure Promotes Chris Aronson to Vice President of North American Sales
September 08, 2014
Cynosure Acquires Assets of RF Medical Device Manufacturer Ellman International, Inc.
August 06, 2014
Cynosure to Present at Canaccord Genuity 34th Annual Growth Conference

Upcoming Events

There are currently no events scheduled.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.